Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 112, Issue 13, 5063-5073, December 15, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

NF-{kappa}B1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms
Blood Banerjee et al. 112: 5063

Supplemental materials for: Banerjee et al

Macrophage cultures. wt and nfkb1−/− bone marrow-derived macrophages were generated using L-cell conditioned medium containing M-CSF as previously described.11 Equivalent numbers of macrophages of both genotypes were seeded into 96 well flat-bottom plates in RPMI1640, 10% fetal bovine serum containing 10% L-cell conditioned medium, 50 µM 2-mercaptoethanol and either left untreated or stimulated with 20 µg/ml LPS.

Measuring macrophage viability. To assess macrophage viability, cultures were first subjected to centrifugation (400 ×g/5 min), the pelleted cells washed and the centrifugation step repeated. Cells were then incubated with 1 µM calcein and 1 µM of ethidium homodimer (in KDS Balanced Salt Solution) for 20 min at 37°C. Cells were then examined under a fluorescence microscope using a 490 nm excitation wavelength filter. Viable cells (green) and apoptotic cells (red) were counted in a defined field. At least 200 cells/well were counted and in each experiment there were duplicate or triplicate cultures.

Files in this Data Supplement:

  • Table S1 (PDF, 32.7 KB) -
    Representative spleen cellularities (×106) for wild-type, nfκb1−/−, bim−/−, nfκb1−/−bim−/−, bcl-2T, and nfκb1−/−bcl-2T mice.

  • Figure S1. Bcl-2 transgene expression in wt and nfkb1−/− B cells: Western blot analysis of endogenous mouse Bcl-2 (mBcl-2) and transgenic human (JPG, 26.6 KB) -
    Bcl-2 (hBcl-2) expression in wt, bcl-2T, nfkb1−/− and nfkb1−/−bcl-2T B cells prior to and following LPS stimulation (18 hrs). Actin loading control is shown.





  • Figure S2. Profiles of follicular and marginal zone B-cell populations in nfκb1−/−bim−/− mice (JPG, 178 KB) -
    Spleens from wt, nfκb1−/−, bim−/−, nfκb1−/−bim−/−, bcl-2T, and nfκb1−/−bcl-2T mice were stained with cell surface marker specific antibodies and FACS analysis performed to assess their content of marginal zone (IgM+CD23CD21+) and follicular (IgM+CD23+CD21+) B cells. Representative FACS plots show CD21 versus IgM staining profiles of CD23+ or CD23 gated populations. The total number of each B-cell population is shown for mice of each genotype. The data shown are representative of at least 3 mice per genotype and three independent experiments.





  • Figure S3 (JPG, 40.5 KB) -
    (A) 4-HT induces ERK activation in the WEHI 231 B lymphoma cell line expressing a c-Raf:ER fusion protein. WEHI 231 B cells infected with the retrovirus pMy-IRES-GFP-Raf:ER were untreated or treated with 4-HT over a 2 hr period. Total cell lysates were subjected to Western blotting using antibodies specific for p-ERK, Bim and ERK. (B) The proliferation of LPS stimulated B cells is blocked by constitutive Raf:ER activation. wt, nfkb1−/−, Raf:ER, and nfkb1−/−Raf:ER B cells were activated in culture for 48 hrs with LPS, 4-HT or LPS and 4-HT. B-cell proliferation was assessed by 3H-thymidine incorporation. The results represent means ± SEM of 3 independent experiments, each performed in triplicate. Incorporated 3H-thymidine of less than 103 cpm is indicated as <103 (lanes 5–8).





  • Figure S4 (JPG, 41.2 KB) -
    (A) Time course of LPS induced Bim phosphorylation in B cells. Lysates isolated from wt B cells prior to or following LPS stimulation for 1, 1.25, 2, 4 and 6 hrs were fractionated on 2D-gels and subjected to Western blot analysis using Bim specific antibodies. The symbols + and – refer to the anode and cathode respectively. (B) The 4-HT induced phosphorylation of Bim in B cells expressing Raf:ER is blocked by PD98059. WEHI 231 B cell infected with the retrovirus pMy-IRES-GFP-Raf:ER were either untreated, or treated for 2hrs with PD98059, 4-HT or PD98059 plus 4-HT. Total cell lysates fractionated on 2D-gels were subjected to Western blot analysis using Bim specific antibodies. The symbols + and – refer to the anode and cathode respectively.





  • Figure S5. LPS does not induce increased apoptosis in nfkb1−/− macrophages (JPG, 14.7 KB) -
    Equivalent numbers of wt and nfkb1−/− bone marrow derived macrophages were left untreated or stimulated with LPS over a 48 hr period. Cell viability at T0, T24 and T48 hrs was determined by microscopic examination of cells stained with calcein and ethidium. The results represent the mean ± SEM of 3 independent experiments.





  • Figure S6. The increased spontaneous and LPS induced death of nfkb1−/− B cells is not influenced by the absence of the BH3-only pro-apoptotic protein Bad (JPG, 54.5 KB) -
    wt, nfkb1−/−, bad−/−, and nfkb1−/−bad−/− B cells were cultured in simple medium or stimulated with LPS over 48 hr. The viability of B cells from mice of all genotypes was >98% prior to culture. (A) Cells cultured in the absence of mitogenic activation were harvested after 24 and 48 hrs and the frequency of apoptotic cells determined. (B) B cells were stimulated with LPS for 24 and 48 hrs, after which levels of cell death were determined. Both sets of results represent the mean ± SEM of 3 independent experiments.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020